{
    "title": "Experimental Alzheimer's drug could be approved by MARCH after FDA agrees to speed its review of the first new treatment in 17 years for the memory loss disease",
    "url": "https://www.dailymail.co.uk/health/article-8604187/FDA-accepts-Biogens-application-Alzheimers-drug-decision-March.html",
    "date": "2020-08-07",
    "keywords": [
        "drug",
        "review",
        "biogen",
        "agency",
        "analyst",
        "approval",
        "treatment",
        "aducanumab",
        "brain",
        "fda",
        "application",
        "percent",
        "disease",
        "function",
        "data",
        "latestage",
        "year",
        "share",
        "beta",
        "street",
        "food",
        "administration",
        "mindrobbing",
        "progression",
        "population",
        "control",
        "prevention",
        "cdcthe",
        "medication",
        "priority",
        "decision",
        "march",
        "statement",
        "state",
        "deal",
        "yatin",
        "suneja",
        "saidbiogen",
        "company",
        "voucher",
        "consideration",
        "sign",
        "interest",
        "baby",
        "cognitive",
        "cause",
        "dementia",
        "article",
        "cycle",
        "phil",
        "nadeau",
        "protein",
        "form",
        "hallmark",
        "memory",
        "loss",
        "decline",
        "maker",
        "announcement",
        "journey",
        "development",
        "study",
        "resultsthe",
        "firm",
        "benefit",
        "disappointment",
        "target",
        "fact",
        "help",
        "dosage",
        "timing",
        "studiesthere",
        "ton",
        "dataset",
        "paul",
        "meeting",
        "date",
        "recommendation",
        "committee",
        "clearing",
        "michael"
    ],
    "category": [
        "health"
    ]
}